Published • loading... • Updated
Amgen Drug Reviewed Amid Deaths - Los Angeles Business Journal
Summary by labusinessjournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Amgen Drug Reviewed Amid Deaths - Los Angeles Business Journal
Sales of the problematic Amgen Inc. drug Tavneos resumed late last week in Japan with a new warning label after several patient deaths potentially linked to the drug. The drug’s future in the United States is still uncertain amid renewed regulatory scrutiny following revelations of alleged data manipulation in clinical trials for the drug several years ago. Tavneos, which also goes by the generic name avacopan, was developed by San Carlos-based …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
